Management of central venous catheters in patients with cancer and candidemia

被引:121
|
作者
Raad, I
Hanna, H
Boktour, M
Girgawy, E
Danawi, H
Mardani, M
Kontoyiannis, D
Darouiche, R
Hachem, R
Bodey, GP
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Univ Texas, Sch Publ Hlth, Houston, TX USA
关键词
D O I
10.1086/382874
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the need and appropriate timing of catheter removal in patients with candidemia, the records for 404 patients with cancer and central venous catheters (CVCs) who developed candidemia during the period of 1993 - 1998 were retrospectively reviewed. Of the total 404 cases of candidemia, 241 (60%) were due to a primary source, 111 (27%) were catheter related, and 52 (13%) were secondary cases of candidemia caused by a source other than the catheter. Multivariate analysis showed that catheter removal less than or equal to 72 h after onset improved response to antifungal therapy exclusively in patients with catheter-related candidemia (P = .04). Pp. 04 Clinical characteristics that suggested a noncatheter source for the candidemia were disseminated infection (P < .01), previous chemotherapy (P < .01), previous corticosteroid therapy (P = .02), and poor response to antifungal therapy (P < .03). CVC removal <= 72 h after onset should be considered in patients with suspected catheter-related candidemia who have no evidence of dissemination, recent corticosteroid therapy, or chemotherapy.
引用
收藏
页码:1119 / 1127
页数:9
相关论文
共 50 条
  • [1] Should the Guidelines for Management of Central Venous Catheters in Patients with Candidemia Be Changed Now?
    Brass, Eric P.
    Edwards, John E., Jr.
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (03) : 304 - 306
  • [2] Removal of central venous catheters from patients with candidemia
    Lazzarini, L
    Luzzati, R
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (08) : 1021 - 1021
  • [3] Management of central venous catheters in patients with cancer and candidemia. (vol 38, pg 1119, 2004)
    Raad, I
    Hanna, H
    Boktour, M
    Girgawy, E
    Danawi, H
    Mardani, M
    Kontoyiannis, D
    Darouiche, R
    Hachem, R
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (08) : 1264 - 1264
  • [4] Removal of central venous catheters from patients with candidemia - Reply
    Nucci, M
    Anaissie, EJ
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (08) : 1022 - 1022
  • [5] The role of central venous catheters in persistent neonatal candidemia
    Hashimoto, LN
    Karlowicz, MG
    Kelly, RE
    Buescher, ES
    PEDIATRIC RESEARCH, 2000, 47 (04) : 341A - 341A
  • [6] Candidemia in cancer patients: Impact of early removal of non-tunneled central venous catheters on outcome
    Liu, C. Y.
    Huang, L. J.
    Wang, W. S.
    Chen, T. L.
    Yen, C. C.
    Yang, M. H.
    Hsiao, L. T.
    Liu, C. Y.
    Chen, P. M.
    Chiou, T. J.
    JOURNAL OF INFECTION, 2009, 58 (02) : 154 - 160
  • [7] Management of Complications Related to Central Venous Catheters in Cancer Patients: An Update
    Linnemann, Birgit
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (03): : 382 - 394
  • [8] Anticoagulation for patients with cancer and central venous catheters
    Akl, Elie A.
    Vasireddi, Srinivasa Rao
    Gunukula, Sameer
    Yosuico, Victor E. D.
    Barba, Maddalena
    Sperati, Francesca
    Cook, Deborah
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (02):
  • [9] Thrombosis and central venous catheters in cancer patients
    Young, A. M.
    Anderson, S.
    Ashton, A.
    Begum, G.
    Hunter, D.
    Wronski, S.
    THROMBOSIS RESEARCH, 2007, 120 : S161 - S161
  • [10] Anticoagulation for patients with cancer and central venous catheters
    Akl, Elie A.
    Vasireddi, Srinivasa Rao
    Gunukula, Sameer
    Yosuico, Victor E. D.
    Barba, Maddalena
    Sperati, Francesca
    Cook, Deborah
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (04):